AcuityBio Overview
- Year Founded
-
2008

- Status
-
Acquired/Merged
- Employees
-
3

- Latest Deal Type
-
M&A
- Investors
-
1
AcuityBio General Information
Description
Developer of bio-compatible and biodegradable drug-eluting surgical products designed to commercialize novel polymer drug delivery technologies. The company's products are implemented with safety and efficacy in preclinical models, long-term targeted delivery of therapeutic levels of paclitaxel to areas at highest risk for harboring residual cancer cells and can be applied to additional indications besides lung cancer, enabling surgeons to administer during initial tumor removal surgery and prevent a recurrence.
Contact Information
Website
www.acuitybio.comCorporate Office
- 321 Walnut Street
- Suite 300
- Newton, MA 02460
- United States
Corporate Office
- 321 Walnut Street
- Suite 300
- Newton, MA 02460
- United States
AcuityBio Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Merger/Acquisition | 01-Jun-2021 | Completed | Generating Revenue | |||
6. Later Stage VC | 10-Feb-2020 | Completed | Generating Revenue | |||
5. Later Stage VC (Series A) | 13-Nov-2017 | Completed | Generating Revenue | |||
4. Grant | Completed | Generating Revenue | ||||
3. Grant | 01-Jul-2013 | Completed | Generating Revenue | |||
2. Grant | 16-Sep-2011 | $1.4M | Completed | Generating Revenue | ||
1. Grant | 01-Jan-2008 | $500K | Completed | Startup |
AcuityBio Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
AcuityBio Patents
AcuityBio Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2989171-A1 | Implantable drug delivery compositions and methods of use thereof | Pending | 18-Jun-2015 | ||
AU-2016280274-B2 | Implantable drug delivery compositions and methods of use thereof | Active | 18-Jun-2015 | ||
AU-2016280274-A1 | Implantable drug delivery compositions and methods of use thereof | Active | 18-Jun-2015 | ||
US-20180193282-A1 | Implantable drug delivery compositions and methods of use thereof | Active | 18-Jun-2015 | ||
JP-2021107420-A | Implantable drug delivery compositions and methods of use thereof | Pending | 18-Jun-2015 | A61K9/0024 |
AcuityBio Signals
AcuityBio Former Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Internal Revenue Service | Government | |||
National Cancer Institute | Government | |||
U.S. Department of Health and Human Services | Government |
AcuityBio FAQs
-
When was AcuityBio founded?
AcuityBio was founded in 2008.
-
Where is AcuityBio headquartered?
AcuityBio is headquartered in Newton, MA.
-
What is the size of AcuityBio?
AcuityBio has 3 total employees.
-
What industry is AcuityBio in?
AcuityBio’s primary industry is Drug Delivery.
-
Is AcuityBio a private or public company?
AcuityBio is a Private company.
-
What is AcuityBio’s current revenue?
The current revenue for AcuityBio is
. -
How much funding has AcuityBio raised over time?
AcuityBio has raised $2.83M.
-
Who are AcuityBio’s investors?
Internal Revenue Service, National Cancer Institute, and U.S. Department of Health and Human Services have invested in AcuityBio.
-
When was AcuityBio acquired?
AcuityBio was acquired on 01-Jun-2021.
-
Who acquired AcuityBio?
AcuityBio was acquired by Cook Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »